Cimpress price target raised to $110 from $90 at Truist

Truist raised the firm’s price target on Cimpress to $110 from $90 and keeps a Buy rating on the shares. The company reported strong Q2 results, comfortably exceeding expectations with a solid performance at Vista in particular, which is a key indication that Cimpress is finally on the other side of its multi-year tech, branding and products retooling efforts, the analyst tells investors in a research note.